Insider Shareholders with Direct Ownership of Ligand Pharmaceuticals Inc (LGND)
This section provides a comprehensive overview of the insiders with direct ownership of Ligand Pharmaceuticals Inc (LGND). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LIGAND PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John L Higgins
Director |
425,629 | 226,632 | 417,695 $50.4 Million | 31 |
Dec 28, 2022
Reduced 1.25%
|
| 109,219 | 102,445 | 162,187 $19.6 Million | 18 |
Nov 01, 2022
Reduced 11.13%
|
|
|
Todd C Davis
Chief Executive Officer |
99,654 | 20,336 | 130,342 $15.7 Million | 16 |
Feb 15, 2025
Reduced 3.16%
|
|
Jason Aryeh
Director |
9,327 | 0 | 78,080 $9.42 Million | 6 |
Jun 14, 2024
Added 1.58%
|
|
Matthew E Korenberg
President & COO |
124,504 | 105,438 | 50,777 $6.13 Million | 34 |
Sep 23, 2024
Reduced 0.39%
|
|
John W Kozarich
Director |
27,999 | 12,151 | 43,775 $5.28 Million | 13 |
Jun 14, 2024
Added 2.78%
|
|
Stephen L Sabba
Director |
27,999 | 22,971 | 30,178 $3.64 Million | 10 |
Jun 14, 2024
Added 3.98%
|
|
John L Lamattina
Director |
11,269 | 7,241 | 29,515 $3.56 Million | 8 |
Nov 27, 2024
Reduced 7.54%
|
| 2,634 | 1,004 | 28,820 $3.48 Million | 4 |
Nov 01, 2022
Reduced 3.37%
|
|
|
Andrew Reardon
CLO & Secretary |
39,241 | 22,886 | 28,368 $3.42 Million | 17 |
Feb 15, 2025
Reduced 3.0%
|
|
Octavio Espinoza
Chief Financial Officer |
48,410 | 35,084 | 23,879 $2.88 Million | 26 |
Feb 15, 2025
Reduced 4.86%
|
| 18,839 | 36,129 | 23,825 $2.87 Million | 10 |
Nov 01, 2022
Reduced 33.39%
|
|
|
Nancy Ryan Gray
Director |
4,028 | 934 | 6,885 $830,812 | 5 |
Jun 14, 2024
Added 15.39%
|
|
Jason Haas
Director |
4,144 | 0 | 5,397 $651,255 | 3 |
Jun 14, 2024
Added 18.83%
|
|
Martine Zimmermann
Director |
3,537 | 0 | 3,537 $426,809 | 2 |
Jun 14, 2024
Added 26.14%
|
| 1,634 | 1,004 | 2,892 $348,977 | 3 |
Nov 01, 2022
Reduced 25.77%
|
|
| 2,165 | 1,004 | 1,161 $140,097 | 3 |
Nov 01, 2022
Reduced 46.37%
|